Clinical Trial Update: Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients [NA]

View source ↗

Summary

This clinical trial update reports on the prognostic value of tumor hypoxia in non-small cell lung cancer as measured by 18F-FMISO breath-hold PET/CT. Results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non-Small-Cell-Lung Cancer (NSCLC) | NA | Status: COMPLETED | Results posted: 2025-04-30